Precision Medicine Technology
Park City company develops new ground breaking cancer treatment | 8/25/2020
… and PACAP overexpressed on the surface of cancer cells. Combined with medical imaging methods, NuView’s test provides physicians a more precise diagnosis and allows for targeted therapy delivery. The Cancer Consortium recently called NuView’s precision medicine technology a “breakthrough…uniquely positioned to confirm cancer” on the cell surface with greater than 95 percent sensitivity. (1) NuView seeks to help patients avoid surgical biopsy For patients, theranostics diagnostics avoids painful surgical …
Trobix Bio completed Series A funding by a leading Japanese/Singapore fund | PR Newswire | 7/29/2020
… range of bacterial pathogens, and actively sensitize these pathogens to antibiotics. The company’s lead product, TBX101, aims to treat patients carrying gut antimicrobial resistant bacteria, resulting in an antibiotic sensitive gut microbiome. Trobix Bio’s precision medicine technology minimizes resistance development to TBX101. About Chartered Opus Chartered Opus is a production platform for investment products combining structural and technological innovations to a new methodology in Structured Products. Opus is the preferred …
PROTXX and University of Alberta Announce Remote Personalized Healthcare Collaboration for Patients with Multiple Sclerosis Published: Jun 30, 2020 MENLO PARK , Calif. and EDMONTON, Alberta , June 30, 2020 /PRNewswire/ – Silicon Valley, California and Calgary, Alberta based precision medicine technology pioneer PROTXX and the University of Alberta in Edmonton, Alberta today announced a new research collaboration that will leverage the PROTXX precision healthcare platform for remote personalized health management of patients …
PROTXX and AltaML form wearable device and machine learning alliance | 6/10/2020
PROTXX and AltaML form wearable device and machine learning alliance Share ajohney 3 hours ago Precision medicine technology company PROTXX and artificial intelligence (AI) and machine learning (ML) product developer AltaML have partnered to augment the data analytics capabilities of the PROTXX precision healthcare platform. The collaboration aims to enable PROTXX platform to support automated diagnoses of neurodegenerative medical conditions. The platform is designed to replace expensive clinical equipment and …
PROTXX and AltaML Announce Wearable Device and Machine Learning Collaboration | Benzinga | 6/9/2020
MENLO PARK, Calif. and EDMONTON, Alberta , June 9, 2020 /CNW/ – Silicon Valley- and Calgary -based precision medicine technology pioneer PROTXX and Alberta -based artificial intelligence (AI) and machine learning (ML) product developer AltaML today announced that they have launched a collaboration to expand the data analytics capabilities of the PROTXX precision healthcare platform to support automated diagnoses of neurodegenerative medical conditions. The PROTXX precision healthcare platform integrates wearable sensor and …
Precision Medicine Tech Company ‘Syapse’ Announces $30 Million Funding | 5/28/2020
… making medicine and the science of applying it to the right cause. In technical parlance, we can call Precision Medicine as “programmatic” clinical drug management, like we have programmatically-controlled advertising. Syapse, a leading Precision medicine technology company, has been working closely with the oncologists and drug companies to develop ‘real-world evidence in oncology.’ Today, Syapse has announced $30 million in new equity funding to accelerate the creation and …
New York City, NY: April 02, 2020 – Published via (Wired Release) – The Exclusive Research Report on Precision Medicine with Industry-Primary Research, Secondary Research, Product Research, Revenue, Emerging Trends and Top Growing Companies 2020-2029″. The report points that are discussed within the systematic approach are the major market players that are involved in the precision medicine such as manufacturers , raw material suppliers, equipment suppliers, end users, traders, distributors and etc …
… there is tremendous optimism in the potential of precision medicine. However, reimbursement and generating a return on investment are significant challenges, CIOs surveyed said. Barriers to entry are high, and, so far, adoption of precision medicine technology is currently limited to relatively few organizations—only 12% of interviewed health systems, mostly larger organizations, can be categorized as mature in their precision medicine efforts, the report said. On average, those organizations …
Bioinformatics Analyst I | 10/8/2019
Bioinformatics Analyst I Job Description OmniSeq is focused on delivering patients with cancer better access to the power of precision medicine technology and new hope for better outcomes. We provide oncology groups, hospitals and healthcare systems with the first-ever fusion of clinical genomics and a comprehensive information technology solution with easy access to actionable insights about their patient’s condition and available treatment options. OmniSeq currently offers to the commercial …
Four precision medicine experts – a groundbreaking provider organization and three precision medicine technology vendors – offer healthcare CIOs and other leaders their expertise for getting started with the nascent area of medicine. Implementation best practices: The best approaches to precision medicine September 11, 2019 12:38 PM Precision medicine is just starting to gain ground in the healthcare industry. Most patients have yet to have medical care designed to enhance effectiveness or …
University partners with AI company to further medical research | 9/5/2019
… treatment that takes into account variations in people’s genes, environment and lifestyle. The University will gain access to all of the AI problems Infosys is trying to solve. In order to implement AI into precision medicine technology , any and all errors must be figured out beforehand. University researchers and students will be taking these problems and implementing them in their research. In turn, once the problems with the AI are …
Infosys, an international IT consulting firm, announced a partnership with the University of Illinois at Urbana-Champaign to develop new technologies and systems for use in precision medicine. The collaboration will pair the Infosys Nia platform, which uses artificial intelligence and machine learning to automate complex business processes and data management, with UIUC’s expertise in the areas of computing systems, bioinformatics and genomic applications. The goal of the partnership is …
CHARLOTTESVILLE, Va. , April 23, 2019 /PRNewswire/ – AMPEL BioSolutions, a precision medicine technology company and MedNet Solutions, an eClinical technology company, today announced they will host and sponsor a Virginia Biotechnology Association ( Virginia Bio ) educational and networking event. Virginia Bio is a diverse network of industry leaders focused on generating growth of the biotechnology industry in the state. The event, Virginia Bio’s quarterly “ Beer and Bio” event , will be held on …
Oncodesign: 2018 Annual Results | Business Wire | 4/11/2019
… outlook Oncodesign has restated its turnover target of €40 million in 2020, including €30 million from the Service business. Its roadmap is as follows : Continue to roll out its strategic technology drivers via its precision medicine technology platform Accelerate the pipeline’s emergence and maturation while launching a clinical trial by year-end 2020 of one of the therapeutic compounds based on Nanocyclix technology Move the mutated anti-EGFR radiotracer (phase …
… and Chief Scientific Officer, will present at the 36 th Annual J.P. Morgan Healthcare Conference on Monday, January, 8 at 3:00 p.m. PST in San Francisco, Calif. Company leadership will discuss its two proprietary, precision medicine technology platforms, ADAPT Biotargeting System ™ and Caris Molecular Intelligence ® , in addition to taking questions from the audience. About Caris Life Sciences ® Caris Life Sciences ® is a leading innovator in molecular science focused on fulfilling …
… Chief Scientific Officer, will present at the 29 th Annual Piper Jaffray Healthcare Conference on Tuesday, November 28, 2017 at 3:10 p.m. EST in New York, NY . Company leadership will discuss its two proprietary, precision medicine technology platforms, ADAPT Biotargeting System ™ and Caris Molecular Intelligence ® , in addition to taking questions from the audience. About Caris Life Sciences ® Caris Life Sciences ® is a leading innovator in molecular science focused on fulfilling …
… and his or her ordering physician. This physician conference format helps to maintain the patient-physician relationship while introducing cutting-edge genomic science, empowering physicians to deal with health risks uncovered by IRIS’s proprietary precision medicine technology . Quicker and better interventions result in cutting costs and saving lives. In the workplace, IRIS proposes offering every employee a basic wellness program, offering upper level management a complete DNA analysis as well …
David Spetzler
… David Spetzler , M.S., Ph.D., M.B.A., President and Chief Scientific Officer, will present at the 36 th Annual J.P. Morgan Healthcare Conference on Monday, January, 8 at 3:00 p.m. PST in San Francisco, Calif. Company leadership will discuss its two proprietary, precision medicine technology platforms, ADAPT Biotargeting System ™ and Caris Molecular Intelligence ® , in addition to taking questions from the audience. About Caris Life Sciences ® Caris Life Sciences ® is a leading innovator …
… David Spetzler , M.S., Ph.D., M.B.A., President and Chief Scientific Officer, will present at the 36 th Annual J.P. Morgan Healthcare Conference on Monday, January, 8 at 3:00 p.m. PST in San Francisco, Calif. Company leadership will discuss its two proprietary, precision medicine technology platforms, ADAPT Biotargeting System ™ and Caris Molecular Intelligence ® , in addition to taking questions from the audience. About Caris Life Sciences ® Caris Life Sciences ® is a leading innovator …
About:
Editor:
